NCT01653002View on ClinicalTrials.gov

Methylation Level of SHOX2 in Endobronchial Ultrasound With Real-time Guided Transbronchial Needle Aspiration for Lung Cancer Staging

CompletedOBSERVATIONAL

Enrollment

200

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

February 29, 2012

Study Completion Date

June 30, 2014

Conditions

Lung Cancer With Mediastinal Lymph Node Involvement

Interventions

OTHER

No intervention

Trial Locations (1)

45239

Ruhrlandklinik - Universitätsklinikum Essen, Essen

Sponsors

Collaborators (1)

Epigenomics, Inc

All Listed Sponsors

collaborator

Epigenomics, Inc

INDUSTRY

lead

University Hospital, Essen

OTHER

NCT01653002 - Methylation Level of SHOX2 in Endobronchial Ultrasound With Real-time Guided Transbronchial Needle Aspiration for Lung Cancer Staging | Biotech Hunter | Biotech Hunter